About Arcus
Premier Chemistry. Proven Biology.
Better medicines demand better chemistry. At Arcus, we’re advancing validated biology with exceptional chemistry to create medicines that outperform existing standards of care and deliver meaningful improvements for patients with cancer and immune diseases.
Founded in 2015, Arcus Biosciences is a clinical-stage, global biopharmaceutical company with the goal of developing differentiated molecules and combination therapies.
We believe that discovery is not a commodity, and we have invested in building exceptional small molecule, medicinal chemistry and antibody capabilities to develop medicines that have the potential to improve upon standards of care.
Our Core Principles
Lead with Premier Chemistry
Design molecules with exceptional potency and selectivity, optimized to redefine standards of care and produce oral small molecule medicines built to work in the real world of a patient’s body, not just in the lab.
Build on Proven Biology
Focus on validated mechanisms with strong clinical and scientific evidence, so we can accelerate the development of new medicines that we believe can improve upon existing treatments.
Outperform Standards of Care
Pair validated biology with exceptional chemistry to deliver meaningful improvements for patients with cancer and immune diseases.
